FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019914 [Registered on: 27/06/2019] Trial Registered Prospectively
Last Modified On: 31/05/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to see the effect of Ayurvedic drug in the management of Karnasrava w.s.r. to C.S.O.M. 
Scientific Title of Study   A randomised clinical trial of Karnapichu with Gandhaka Taila, Karnadhupana and Rasnadi Guggulu in the managemaent of Karnasrava w.s.r. to chronic suppurative otitis media (C.S.O.M.) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gulab Chand Pamnani 
Designation  Assistant Professor 
Affiliation  National Institute Of Ayurveda 
Address  Department OF Shalakya Tantra, National Institute Of Ayurveda, Joravar singh Gate, Amer road, Jaipur, Rajasthan, 302002, India
House no.104/33 Vijaypath,Mansarovar,Jaipur, 302020
Jaipur
RAJASTHAN
302002
India 
Phone  9461154942  
Fax    
Email  pamnani.gulab@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gulab Chand Pamnani 
Designation  Assistant Professor 
Affiliation  National Institute Of Ayurveda 
Address  Department OF Shalakya Tantra, National Institute Of Ayurveda, Joravar singh Gate, Amer road, Jaipur, Rajasthan, 302002, India
House no.104/33 Vijaypath,Mansarovar,Jaipur, 302020
Jaipur
RAJASTHAN
302002
India 
Phone  9461154942  
Fax    
Email  pamnani.gulab@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meena Nagar 
Designation  PG Scholar 
Affiliation  National Institute of Ayurveda, Jaipur,Rajasthan 
Address  Department OF Shalakya Tantra, National Institute Of Ayurveda, Joravar singh Gate, Amer road, Jaipur, Rajasthan, 302002, India
C/O Biradhi Lal Nagar house no. 44-A shivpura dadabari Kota, Rajasthan,324009
Kota
RAJASTHAN
302002
India 
Phone  9462973774  
Fax    
Email  dr.meenanagar774@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda, joravar Singh gate Amer road Jaipur,302002, Rajasthan 
 
Primary Sponsor  
Name  National Institute Of Ayurveda Jaipur 
Address  National Institute Of Ayurveda, Amer Road, Joravar Singh Gate, Jaipur, 302002, Rajasthan, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Meena Nagar  National Institute Of Ayurveda, Jaipur  OPD no. 13, P G Department of Shalakya tantra, National Institute Of Ayurveda, Amer Road, Joravar singh Gate, Jaipur, 302002, Rajasthan,India
Jaipur
RAJASTHAN 
9462973774

dr.meenanagar774@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee National Institute of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H661||Chronic tubotympanic suppurative otitis media,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Karnadhupana locally along with Rasnadi Guggulu  Karnadhupana outside the ear and into the external auditory canal twice daily for 30 days 
Intervention  Karnapichu with Gandhaka Taila along with Rasnadi Guggulu  Karnapichu (8 to 16 drops) twice a day for 30days and Rasnadi Guggulu (500 mg)twice daily for 30 days 
 
Inclusion Criteria  
Age From  8.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients presenting with signs and symptoms of karnasrava described as per Ayurvedic and modern parlance 
 
ExclusionCriteria 
Details  1. Age below 8 years and above 60 years.
2. Systemic diseases like uncontrolled DM, Meningitis,Tuberculosis,HTN etc
3. History of long term intake of ototoxic drugs
4. C.S.O.M. with complications like acute mastoiditis, petrositis, facial paralysis, adenoids, tonsilitis, labyrithitis etc.
5. Pregnant women. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Karnapichu with Gandhaka Taila,Karnadhupana and Rasnadi Guggulu in the management of Karnasrava(C.S.O.M.)  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
Any adverse event reported voluntarily, observed or enquired.Recurrence in sign and symptoms of Karnasrava(C.S.O.M.)  2 Months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)
Modification(s)  
13/11/2019 
Date of Study Completion (India) 08/02/2020 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

The study will be a randomised clinical phase1 trial.The screened patients will be randomly divided in two groups using computerized randomization method for unbiased allocation.

Group A: Patients will be treated with Karnapichu with Gandhaka Taila along with Rasnadi Gugglu.

Group B:Patients will be treated with Karnadhupana along with Rasnadi Guggulu.

Aims and objectives:

  • To study Karnasrava in both Ayurveda and modern parlance.
  • To evaluate the efficacy of Karnapichu and Karnadhupana on Karnasrava clinically.
  • To evaluate the effect of Rasnadi Guggulu on Karnasrava clinically.
  • To compare the efficacy of trial drugs.

 


 
Close